Skip to main content
. 2021 Mar 5;42(2):NP115–NP124. doi: 10.1093/asj/sjab114

Figure 5.

Figure 5.

A 50-year-old female patient at baseline (A) and at Month 4 (B). Patient applied bimatoprost daily to eyelid margins and received 4.0 mL VYC-20L for midface volume deficiency, 3.7 mL HYC-24L for nasolabial folds, oral commissures, and perioral lines, and 1.6 mL HYC-24L+ for oral commissures and marionette lines; onabotulinumtoxinA was injected for glabellar lines (20 U) and crow’s feet lines (12 U per side) at Month 3. At Month 4, Aging Appearance Appraisal Scale score improved by 15 points and Psychological Well-being Scale score by 12 points; Social Confidence Scale scores were similar to baseline (all FACE-Q scores noted here are raw, untransformed scores). The patient rated herself as looking 6 years younger than her actual age on the FACE-Q Age Appraisal VAS.